Imaging end points for monitoring neuroprotection in Parkinson's disease

被引:37
作者
Brooks, DJ
机构
[1] Hammersmith Hosp, Imperial Coll, MRC, Ctr Clin Sci,Fac Med, London W12 0NN, England
[2] Hammersmith Hosp, Imperial Coll, Div Neurosci, London W12 0NN, England
关键词
D O I
10.1002/ana.10480
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In this review, the potential role of positron emission tomography and single-photon emission computed tomography as biological markers for following the progression of Parkinson's disease (PD) is discussed, and their value for assessing the efficacy of putative neuroprotective agents in PD is considered. It is concluded that functional imaging provides a valuable adjunct to clinical assessment when judging the efficacy of neuroprotective approaches to PD.
引用
收藏
页码:S110 / S118
页数:9
相关论文
共 72 条
[31]   THE CORE ASSESSMENT PROGRAM FOR INTRACEREBRAL TRANSPLANTATION [J].
LANG, AE ;
BENABID, AL ;
KOLLER, WC ;
LOZANO, AM ;
OBESO, JA ;
OLANOW, CW ;
POLLAK, P .
MOVEMENT DISORDERS, 1995, 10 (04) :527-528
[32]   CORE ASSESSMENT PROGRAM FOR INTRACEREBRAL TRANSPLANTATIONS (CAPIT) [J].
LANGSTON, JW ;
WIDNER, H ;
GOETZ, CG ;
BROOKS, D ;
FAHN, S ;
FREEMAN, T ;
WATTS, R .
MOVEMENT DISORDERS, 1992, 7 (01) :2-13
[33]  
LARUELLE M, 1994, J NEUROCHEM, V62, P978
[34]  
Leber P, 1997, ALZ DIS ASSOC DIS, V11, pS10
[35]  
Lee CS, 2000, ANN NEUROL, V47, P493, DOI 10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO
[36]  
2-4
[37]   COGNITIVE DEFICITS IN THE EARLY STAGES OF PARKINSONS-DISEASE [J].
LEES, AJ ;
SMITH, E .
BRAIN, 1983, 106 (JUN) :257-270
[38]   Progression of parkinsonian signs in Parkinson disease [J].
Louis, ED ;
Tang, MX ;
Cote, L ;
Alfaro, B ;
Mejia, H ;
Marder, K .
ARCHIVES OF NEUROLOGY, 1999, 56 (03) :334-337
[39]  
Marek K, 2002, JAMA-J AM MED ASSOC, V287, P1653
[40]   [123I]β-CIT SPECT imaging assessment of the rate of Parkinson's disease progression [J].
Marek, K ;
Innis, R ;
van Dyck, C ;
Fussell, B ;
Early, M ;
Eberly, S ;
Oakes, D ;
Seibyl, J .
NEUROLOGY, 2001, 57 (11) :2089-2094